NCT03020979
- Conditions
- Apatinib, Malignant Ascites
- Locations
-
- Qiong Wu Bengbu, Anhui, China
Clinical trial condition
Malignant Ascites
Explore clinical trials studying Malignant Ascites. Study availability and eligibility vary by location and protocol.
24 public trials
6 recruiting studies
Malignant Ascites trial results
NCT07658196
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adenocarcinoma, Mucinous, +18 more
- Locations
-
- Rhode Island and the Miriam Hospitals (Brown University Health) Providence, Rhode Island, United States
Recruiting
Dual-targeting VEGFR1 and PD-L1 CAR-T for Pleural, Peritoneal, or Leptomeningeal Metastases
NCT05477927
- Conditions
- Central Nervous System Neoplasms, Leptomeningeal Metastases, Malignant Ascites, +8 more
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China
- Conditions
- Malignant Ascites
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
NCT07007988
- Conditions
- Malignant Ascites
- Locations
-
- Shanghai Gobroad Cancer Hospital Shanghai, Shanghai Municipality, China
NCT06016179
- Conditions
- Malignant Ascites, Malignant Pleural Effusion, Neoplasms, +8 more
- Locations
-
- Allegheny Health Network Cancer Institute Pittsburgh, Pennsylvania, United States
Not yet recruiting
At-Home Paracentesis for Cancer-Related Malignant Ascites (Paracentesis)
NCT07490626
- Conditions
- Malignant Ascites
- Locations
-
- Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States
Not yet recruiting
NK521 in the Treatment of Advanced Solid Tumors
NCT07657416
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +24 more
- Locations
-
- 1st affiliated hospital of Anhui Medical University Hefei, Anhui, China
Not yet recruiting
WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I)
NCT07615894
- Conditions
- Advanced Solid Tumors, Malignant Ascites, Malignant Pleural Effusions, +9 more
- Locations
-
- West China Hospital of Sichuan University Chengdu, Sichuan, China
Enrolling by invitation
Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites
NCT05745233
- Conditions
- Malignant Ascites
- Locations
-
- China Medical University Hospital Taichung, Please Select, Taiwan